Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.
Tonghua Dongbao Pharmaceutical Dividend Announcement
• Tonghua Dongbao Pharmaceutical announced a annually dividend of ¥0.25 per ordinary share which will be made payable on 2024-05-23. Ex dividend date: 2024-05-23
• Tonghua Dongbao Pharmaceutical annual dividend for 2024 was ¥0.25
• Tonghua Dongbao Pharmaceutical annual dividend for 2023 was ¥0.25
• Tonghua Dongbao Pharmaceutical's trailing twelve-month (TTM) dividend yield is 2.91%
• Tonghua Dongbao Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 291.73%
• Tonghua Dongbao Pharmaceutical's dividend growth over the last five years (2018-2023) was 8.45% year
• Tonghua Dongbao Pharmaceutical's dividend growth over the last ten years (2013-2023) was 2.26% year
Tonghua Dongbao Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-23 | ¥0.25 | annually | 2024-05-23 |
2023-06-09 | ¥0.25 | annually | 2023-06-09 |
2022-10-28 | ¥0.25 | annually | 2022-10-28 |
2022-06-08 | ¥0.30 | annually | 2022-06-08 |
2021-05-31 | ¥0.21 | annually | 2021-05-31 |
2020-05-25 | ¥0.20 | annually | 2020-05-25 |
2019-05-23 | ¥0.20 | annually | 2019-05-23 |
2018-05-25 | ¥0.17 | annually | 2018-05-25 |
2017-06-06 | ¥0.20 | annually | 2017-06-06 |
2016-06-02 | ¥0.20 | annually | |
2015-05-18 | ¥0.20 | annually | |
2014-04-22 | ¥0.20 | annually | |
2013-05-24 | ¥0.20 | annually |
Tonghua Dongbao Pharmaceutical Dividend per year
Tonghua Dongbao Pharmaceutical Dividend growth
Tonghua Dongbao Pharmaceutical Dividend Yield
Tonghua Dongbao Pharmaceutical current trailing twelve-month (TTM) dividend yield is 2.91%. Interested in purchasing Tonghua Dongbao Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Tonghua Dongbao Pharmaceutical Financial Ratios
Tonghua Dongbao Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Tonghua Dongbao Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tonghua Dongbao Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tonghua Dongbao Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tonghua Dongbao Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tonghua Dongbao Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tonghua Dongbao Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tonghua Dongbao Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tonghua Dongbao Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tonghua Dongbao Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tonghua Dongbao Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tonghua Dongbao Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.